Researchers identify #CDC6 as a key regulator of #paclitaxel resistance, showing that its interaction with Tmod3 stabilizes CDC6 to drive #actinremodeling, while CDC6 depletion or actin-targeted combination therapy resensitizes tumors.

#OpenAccess in #STTT: doi.org/10.1038/s413...